Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stuart Parris"'
Autor:
Pelin Demirel, Stuart Parris
Publikováno v:
Technology Analysis & Strategic Management. 27:782-808
Technological innovations are seen as one of the best solutions to mitigate the environmental impacts of economic activity. Yet, the innovative success of firms, especially small- and medium-sized enterprises (SMEs), in the environmental sector is de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea6900508300fd33df03b349014a424
https://doi.org/10.1080/09537325.2015.1019849
https://doi.org/10.1080/09537325.2015.1019849
Publikováno v:
Developing standards to support the synthetic biology value chain
A study identifying the impact that adoption of synthetic biology is likely to have on the global marketplace (buyers, sellers and users) as well as any existing barriers or obstacles preventing the rapid scale-up and commercialisation of the technol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07939af83a713484dc78bc58467a9a2d
https://doi.org/10.7249/rr1527
https://doi.org/10.7249/rr1527
Autor:
Mariana Mazzucato, Stuart Parris
Publikováno v:
Small Business Economics. 44:145-170
Firms across sectors and regions are highly skewed in their ability to engage with innovation and even more skewed in their ability to translate investments in innovation into higher growth. Recent attention has been placed on the importance of ‘hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::566e8b5f02fb22e4d6aa6127efbdf1d4
https://doi.org/10.1007/s11187-014-9583-3
https://doi.org/10.1007/s11187-014-9583-3
Publikováno v:
Critical Perspectives on Accounting. 25:67-77
In this paper we explore whether a financialisation perspective can provide a more empirically satisfying account of recent developments in the pharmaceutical industry than the more commonly used resource-based or transaction cost approaches. Specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a551e266abe55db71b707896b5ecf010
https://doi.org/10.1016/j.cpa.2012.10.003
https://doi.org/10.1016/j.cpa.2012.10.003
Publikováno v:
Galvanising the NHS to adopt innovation: The feasibility and practicality of recommendations from the interim report of the Accelerated Access Review
The Department of Health and the Wellcome Trust, in co-operation with NHS England, asked RAND Europe to conduct a limited consultation with key stakeholders about the practicality of measures and incentives proposed as part of the NHS Accelerated Acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d0acf0fbe14a9e2904bc3af831e7fa
https://europepmc.org/articles/PMC5158272/
https://europepmc.org/articles/PMC5158272/
Autor:
Stuart Parris, Pelin Demirel
Publikováno v:
Strategic Change. 19:343-357
The venture capital sector may not be supportive of radical new clean-technology innovation: a potential concern for the UK's vision of achieving a low carbon economy. Driven by political pressures to cut down CO2 emissions and to find cheaper and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f589fd5c2a01dde8c1ac0d489e98b0b1
https://doi.org/10.1002/jsc.880
https://doi.org/10.1002/jsc.880
Autor:
Stuart Parris, Mariana Mazzucato
Publikováno v:
SSRN Electronic Journal.
Firms across sectors and regions are highly skewed in their ability to engage with innovation, and even more skewed in their ability to translate investments in innovation into higher growth. Recent attention has been placed on the importance of ‘h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19378e56dbada377b52a0a371de3ee9b
https://doi.org/10.2139/ssrn.2736857
https://doi.org/10.2139/ssrn.2736857
Autor:
Alessandro Rosiello, Stuart Parris
Publikováno v:
Rosiello, A & Parris, S 2009, ' The Patterns of Venture Capital Investment in the UK Bio-Healthcare Sector : The Role of Proximity, Cumulative Learning and Specialisation ', Venture Capital, vol. 11, no. 3, pp. 185-211 . https://doi.org/10.1080/13691060902973016
This paper focuses on the patterns of venture capital (VC) investment in dedicated biotech firms (DBFs) in the therapeutic and diagnostic sectors (bio-healthcare). We use a database of 655 UK bio-healthcare deals to map the geographical flows of VC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e835b91da631d6095fbe02bc7e3167
https://www.pure.ed.ac.uk/ws/files/14837781/The_Patterns_Venture_Capital_Investment_in_the_UK_Bio_Healthcare_Sector.pdf
https://www.pure.ed.ac.uk/ws/files/14837781/The_Patterns_Venture_Capital_Investment_in_the_UK_Bio_Healthcare_Sector.pdf